Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Slovakia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Slovakia Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20062
20081
20092
20102
20114
20121
20143
20171
20183
20202
20212
20222
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated5
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC6
Eli Lilly and Company4
Otsuka Pharmaceutical Development & Commercialization, Inc.4
AstraZeneca3
H. Lundbeck A/S2
Intra-Cellular Therapies, Inc.2
Naurex, Inc, an affiliate of Allergan plc2
Neurocrine Biosciences2
Pfizer2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder32
Depressive Disorder4
Mental Disorders3
Mood Disorders3
Anhedonia1
Depressive Disorder, Treatment-Resistant1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.